Cargando…

Prognostic Factor Analysis and Model Construction of Triple-Negative Metaplastic Breast Carcinoma After Surgery

OBJECTIVE: The study aimed to analyze the prognostic factors of patients with triple-negative (TN) metaplastic breast carcinoma (MpBC) after surgery and to construct a nomogram for forecasting the 3-, 5-, and 8-year overall survival (OS). METHODS: A total of 998 patients extracted from the Surveilla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Keying, Chen, Yuyuan, Guo, Rong, Dai, Lanyi, Wang, Jiankui, Tang, Yiyin, Zhou, Shaoqiang, Chen, Dedian, Huang, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261478/ https://www.ncbi.nlm.nih.gov/pubmed/35814407 http://dx.doi.org/10.3389/fonc.2022.924342

Ejemplares similares

A prognostic nomogram based on risk assessment for invasive micropapillary carcinoma of the breast after surgery
por: Chen, Yuyuan, et al.
Publicado: (2023)

Clinicopathologic Features and Prognosis of Female Early Breast Cancer With HER2 Low Expression: A Propensity Score Matched Analysis
por: Dai, Lanyi, et al.
Publicado: (2023)

Nomogram for predicting survival in patients with mucinous breast cancer undergoing chemotherapy and surgery: a population-based study
por: Gao, Ting, et al.
Publicado: (2023)

Nomogram for the prediction of triple-negative breast cancer histological heterogeneity based on multiparameter MRI features: A preliminary study including metaplastic carcinoma and non- metaplastic carcinoma
por: Kong, Qing-cong, et al.
Publicado: (2022)

Construction and validation of prognostic nomogram for metaplastic breast cancer
por: Li, Yongfeng, et al.
Publicado: (2022)

Clinical characteristics and overall survival prognostic nomogram for metaplastic breast cancer
por: Zheng, Caihong, et al.
Publicado: (2023)

Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes
por: Yan, Cheng, et al.
Publicado: (2022)

Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer
por: Geng, Anqi, et al.
Publicado: (2023)

Clinical value of R-spondins in triple-negative and metaplastic breast cancers
por: Coussy, F, et al.
Publicado: (2017)

Comparison of outcomes between metaplastic and triple-negative breast cancer patients
por: Polamraju, Praveen, et al.
Publicado: (2019)

Complete Response of Triple-Negative Metaplastic Carcinoma of the Breast Using Pembrolizumab
por: Ladwa, Amrita, et al.
Publicado: (2023)

Metaplastic Breast Cancer: Characteristics and Survival Outcomes
por: Thapa, Bicky, et al.
Publicado: (2022)

Construction and Identification of New Molecular Markers of Triple-Negative Breast Cancer Stem Cells
por: Liu, Tingting, et al.
Publicado: (2021)

Triple-Negative Metaplastic Breast Carcinoma: Association of Epidermal Growth Factor Receptor Expression With Prognostic Parameters and Clinical Outcome
por: Munawar, Shahzeb, et al.
Publicado: (2021)

Metaplastic Breast Cancer: To Radiate or Not to Radiate?
por: Tseng, Warren H., et al.
Publicado: (2010)

Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer
por: Wu, Song, et al.
Publicado: (2022)

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment
por: Aydiner, Adnan, et al.
Publicado: (2015)

Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
por: González-Martínez, Silvia, et al.
Publicado: (2020)

Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age
por: Cui, Xiang, et al.
Publicado: (2021)

Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
por: Huertas-Caro, Carlos Alexander, et al.
Publicado: (2022)

SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer
por: Zhu, Youzhi, et al.
Publicado: (2023)

Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast Cancer
por: Qin, Wenxing, et al.
Publicado: (2021)

The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database
por: Wang, Jun, et al.
Publicado: (2019)

Differences of Clinicopathological Features between Metaplastic Breast Carcinoma and Nonspecific Invasive Breast Carcinoma and Prognostic Profile of Metaplastic Breast Carcinoma
por: Qiu, Yue, et al.
Publicado: (2022)

LINC00309 is associated with short disease-free survival in breast cancer
por: Huang, Sheng, et al.
Publicado: (2019)

Laparoscopic resection of large oncocytoma with metaplastic ossification: Case report and video
por: Dávila, Francisco J., et al.
Publicado: (2022)

Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer
por: Li, Meng, et al.
Publicado: (2022)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors
por: Djomehri, Sabra I., et al.
Publicado: (2020)

Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype
por: Mao, Jinqian, et al.
Publicado: (2021)

Fibromatosis-Like Metaplastic Carcinoma: A Triple-Negative Breast Cancer with Clinically Indolent Behavior
por: Pham, Khoa Hong, et al.
Publicado: (2022)

Nanomaterial Technology and Triple Negative Breast Cancer
por: Hou, Kai, et al.
Publicado: (2022)

Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis
por: Yang, Xiaolu, et al.
Publicado: (2023)

Novel Prognostic Markers in Triple-Negative Breast Cancer Discovered by MALDI-Mass Spectrometry Imaging
por: Phillips, Leo, et al.
Publicado: (2019)

The roles of small extracellular vesicles as prognostic biomarkers and treatment approaches in triple-negative breast cancer
por: Zhou, Yueyuan, et al.
Publicado: (2022)

Determining prognostic factors and optimal surgical intervention for early-onset triple-negative breast cancer
por: Zheng, Yi-Zi, et al.
Publicado: (2022)

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer
por: Zhang, Hao, et al.
Publicado: (2023)

YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma
por: Zhao, Jikai, et al.
Publicado: (2021)

Rewiring of the Endocrine Network in Triple-Negative Breast Cancer
por: Li, Kaixuan, et al.
Publicado: (2022)

Mutant Phenotype p53 Immunohistochemical Expression Is Associated With Poor Prognostic Parameters and Disease-Free Survival in Triple-Negative Metaplastic Breast Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u43iub4henjsutitqdvbpeqrmn